T1	Participants 34 76	stage II and stage III human colon cancer:
T2	Participants 447 544	254 patients with colon cancer were randomly assigned postoperative ASI or no adjuvant treatment.
T3	Participants 1274 1304	patients with stage II disease
T4	Participants 1682 1704	stage II colon cancer.
